-

CMP Scientific Announces Dr. Darlene Solomon to Advise on Strategy and Technology

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific, a leader in capillary electrophoresis–mass spectrometry (CE-MS) technology, today announced the appointment of Dr. Darlene Solomon, former Chief Technology Officer and Senior Vice President of Agilent Technologies, and member of the National Academy of Engineering as external Executive Advisor of Strategy and Technology.

“We are honored to welcome Dr. Solomon to CMP Scientific,” said James Xia, CEO of CMP Scientific. “Her deep expertise in technology and the bioanalytical industry will be very helpful to CMP as it expands the impact of CE-MS in the biopharma industry. Dr. Solomon’s guidance will help accelerate our mission to bring high-performance, next-generation analytical tools to researchers, drug developers and production teams in manufacturing facilities worldwide.”

“I am excited to advise CMP Scientific at such a dynamic stage of growth,” said Dr. Solomon. “CMP’s CE-MS platform represents a substantial advance for biopharmaceutical characterization and quality assessment. I look forward to contributing to the company’s strategy and technology roadmap as it continues to innovate and expand.”

About CMP Scientific

CMP Scientific is an innovative company focused on advancing capillary electrophoresis–mass spectrometry (CE-MS) technologies for biopharma applications. By combining innovation, precision, ease-of-use, and accessibility, CMP Scientific empowers scientists with tools that improve biotherapeutic characterization, accelerate development timelines, and enhance quality standards across the industry.

To learn more about CMP Scientific and how it is shaping the future of biopharmaceutical analysis, visit www.cmpscientific.com.

Contacts

Media Contact:
James Xia, CEO
CMP Scientific Corp
+1 718-360-7803
james.xia@cmpscientific.com

CMP Scientific


Release Versions

Contacts

Media Contact:
James Xia, CEO
CMP Scientific Corp
+1 718-360-7803
james.xia@cmpscientific.com

More News From CMP Scientific

CMP Scientific's Cutting-Edge Technology Solves CE-SDS Peak Identification Challenge

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific Corp., a leading innovator in advancing biotech analysis, has unveiled a groundbreaking method that addresses a longstanding challenge in the biotechnology industry: the accurate identification of CE-SDS peaks, essential for assessing the purity and quality of antibody therapeutics. By integrating the power of capillary zone electrophoresis-mass spectrometry (CZE-MS) with CE-SDS assays, CMP Scientific has set a new benchmark for precision, speed,...

CMP Scientific Launches BioSummit™ CVA System, the Next-Generation cIEF-MS Platform for Charge Variant Analysis

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific, a leader in capillary electrophoresis-mass spectrometry (CE-MS) technologies, is proud to announce the launch of its highly anticipated BioSummit™ CVA system at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics. This state-of-the-art technology is set to revolutionize online charge variant analysis of recombinant protein therapeutics, offering unparalleled precision and robustness for capillary zone electrophoresis-mass spectrometry...

CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis–Mass Spectrometry Solutions

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific, a leader in Capillary Electrophoresis-Mass Spectrometry (CE-MS) technologies, signed a global co-marketing agreement with Agilent....
Back to Newsroom